{"disease":{"id":"malignant-tumour","name":"malignant tumour"},"drugs":{"marketed":[{"drug_id":"plerixafor","indication_name":"Solid malignant tumours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mozobil","generic_name":"plerixafor","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"C-C chemokine receptor type 2","drug_class":"Hematopoietic Stem Cell Mobilizer [EPC]","quality_score":61,"revenue":null,"mechanism":"Mozobil works by binding to the C-C chemokine receptor type 2, which helps to mobilize hematopoietic stem cells from the bone marrow into the bloodstream."},{"drug_id":"mozobil","indication_name":"Solid malignant tumours","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mozobil","company_name":"University of Washington","drug_phase":"marketed","molecular_target":"Stromal cell-derived factor 1, Atypical chemokine receptor 3, C-C chemokine receptor type 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06153576","title":"The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures","phase":"","overall_status":"COMPLETED","enrollment_count":1120,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT07044336","title":"Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06822413","title":"Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06304818","title":"Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":515,"lead_sponsor_name":"Sinocelltech Ltd.","has_results":false},{"nct_id":"NCT06600022","title":"Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":441,"lead_sponsor_name":"Sinocelltech Ltd.","has_results":false},{"nct_id":"NCT06888830","title":"A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":374,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT02664389","title":"Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation","phase":"NA","overall_status":"COMPLETED","enrollment_count":289,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT07492589","title":"Photo-Acoustic and Ultrasonographic Mammoscope","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Franciscus Gasthuis & Vlietland (Hospital)","has_results":false},{"nct_id":"NCT03589339","title":"NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":145,"lead_sponsor_name":"Nanobiotix","has_results":false},{"nct_id":"NCT02104986","title":"A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT02843204","title":"Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Fuda Cancer Hospital, Guangzhou","has_results":false},{"nct_id":"NCT05850377","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Sociedad de Lucha Contra el Cáncer del Ecuador","has_results":false},{"nct_id":"NCT06857669","title":"Clinical Explorative Optical Breast Investigations","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT04125524","title":"Terahertz Metamaterials for Tumour Marker Concentration Identification","phase":"","overall_status":"SUSPENDED","enrollment_count":90,"lead_sponsor_name":"Durham University","has_results":false},{"nct_id":"NCT02923466","title":"Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Vyriad, Inc.","has_results":false},{"nct_id":"NCT01376505","title":"Vaccine Therapy in Treating Patients With Metastatic Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Robert Wesolowski","has_results":false},{"nct_id":"NCT04765462","title":"Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT02857920","title":"Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Fuda Cancer Hospital, Guangzhou","has_results":false},{"nct_id":"NCT01554371","title":"Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT01286896","title":"Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT06995976","title":"Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT04414150","title":"A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT02853903","title":"Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fuda Cancer Hospital, Guangzhou","has_results":false},{"nct_id":"NCT06929195","title":"Clinical Trial to Evaluate the Tolerance of TQB2210 Injection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04452396","title":"CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia","phase":"NA","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT01151930","title":"Long-Term Compassionate Use Study for Continued Administration of SCB01A-01","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"SynCore Biotechnology Co., Ltd.","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}